Evofem Biosciences resubmits new drug application to US FDA for Amphora for the prevention of pregnancy

This article was originally published here

“Today’s submission represents a significant step forward for Evofem and for the millions of women who are dissatisfied with their current contraceptive options and are eagerly awaiting a

The post Evofem Biosciences resubmits new drug application to US FDA for Amphora for the prevention of pregnancy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply